To advance the clinical research into herpes simplex virus (HSV) infections, the U.S. National Institutes of Health (NIH) today released the Strategic Plan for HSV.
An NIH-wide HSV Working Group was formed in October 2022 to develop this plan, informed by feedback from more than 100 representatives of the research and advocacy communities and stakeholders.
Strategic Plan for Herpes Research Includes Vaccines
Over-Touristed Destinations Include U.S. Hot Spots
There are many cities around the world included in people's bucket-list locations to visit during their lifetime.
According to a team at MoneyTransfers.com, they ranked the most visited cities and countries in the world, and some of the rankings might surprise an avid traveler.
This Most "Over-Touristed" Cities in the World list was published on September 7, 2023.
Vaccine Hesitancy Impacts Dogs Too
A new study from the Boston University (BU) School of Public Health found that 53% of dog owners expressed some Canine vaccine hesitancy (CVH) about protecting their pets from disease.
This study highlights real-world concerns, as about 45% of US households own a dog.
Pre-published in August, this September 22, 2023 analysis considers the prevalence of CVH among dog owners. As Table 3 demonstrates, a significant minority of dog owners consider vaccines administered to dogs to be unsafe (37%), ineffective (22%), and/or unnecessary (30%).
Infection With Omicron Less Likely to Result in Post-COVID-19 Condition
No variation in risk for PCC seen based on number of vaccinations, but previous infection linked to reduced PCC risk
Polio Eradication Misses the Mark
With over thirty-one countries reporting various poliovirus outbreaks in 2023, the goal of eradicating polio this year has become evasive.
Last year, the total number of poliomyelitis samples collected in countries with poliovirus transmission was 12,259 from 40 countries, an increase from 2021.
The Independent Monitoring Board (IMB) recently shared its decade-long perspective on polio eradication. When the IMB was formed, more than 90% of the burden of paralytic polio worldwide had been reduced.
Polio Eradication Misses the Mark in 2023
With over thirty-one countries reporting various poliovirus outbreaks in 2023, the goal of eradicating polio this year has become evasive.
Last year, the total number of poliomyelitis samples collected in countries with poliovirus transmission was 12,259 from 40 countries, an increase from 2021.
The Independent Monitoring Board (IMB) recently shared its decade-long perspective on polio eradication. When the IMB was formed, more than 90% of the burden of paralytic polio worldwide had been reduced.
Protein-based Vaccines Reduce COVID-19 Symptoms
After three and a half years after the SARS-CoV-2 betacoronavirus began infecting people, 183 separate vaccines have entered clinical development.
Given this unprecedented response by vaccine developers, it could easily be assumed that COVID-19 vaccines have revealed all there is to know.
However, in The Lancet Respiratory Medicine, Gustavo Dayan and colleagues report the results of a phase 3 efficacy trial of a bivalent protein-based SARS-CoV-2 vaccine, offering new insights into vaccine-mediated protection against COVID-19.
Tobacco, Cannabis Use Tied to High Rates of Self-Reported Mental Health Issues
Daily use of cigarettes, e-cigarettes, and cannabis associated with both anxiety and depression
BNT162b2 Vaccination Linked to Lower Risk for COVID-19 Encounters in Children Under 5
Vaccination linked to reduced odds ratio of COVID-19-related emergency department or urgent care encounter, outpatient visits
Immune Response Not Inferior With Coadministration of COVID-19, Flu Shots
Similar immune response and no increase in rate of reactogenicity events seen with coadministration versus COVID-19 vaccine alone